Investigation of the Epidemiological Factors Associated With the Development of Amyotrophic Lateral Sclerosis (ALS)
NCT03366506 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2021-02-10
Summary
Investigation of the epidemiological factors associated with amyotrophic lateral sclerosis (ALS) in Israel with a view to future international collaboration. Particularly addressing:-
1. Differences between ethnic subgroups
2. Differences between immigrant and native-born populations
3. Differences according to military service profile Clinical features gathered at each routine visit ,throughout the entire course of the disease, will be recorded in database format, in order to correlate with potential epidemiological factors.
Conditions
Interventions
- OTHER
-
Observation
Sponsors & Collaborators
-
Hadassah Medical Organization
lead OTHER
Principal Investigators
-
Marc Gotkine, MBBS · Hadassah Medical Organization
Eligibility
- Min Age
- 12 Years
- Max Age
- 120 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-03-09
- Primary Completion
- 2049-03-31
- Completion
- 2050-01-31
Countries
- Israel
Study Locations
More Related Trials
-
Autologous Cultured Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in ALS Patients.
NCT01051882 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Determining Feasibility and Acceptability of Sharing Video Recordings With Patients With ALS and Caregivers
NCT04719403 ·Status: COMPLETED ·Phase: NA
-
Autologous Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT01777646 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS)
NCT00330681 ·Status: COMPLETED ·Phase: PHASE3
-
The National Amyotrophic Lateral Sclerosis Registry
NCT01772602 ·Status: RECRUITING
-
ALS Research Collaborative
NCT06885918 ·Status: RECRUITING
-
A Study to Evaluate Transplantation of Astrocytes Derived From Human Embryonic Stem Cells, in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT03482050 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Determinants of Disease Severity in Amyotrophic Lateral Sclerosis
NCT00004457 ·Status: UNKNOWN
-
Clinical Trial - Analyzing Participation Experiences Of Amyotrophic Lateral Sclerosis Patients
NCT05423678 ·Status: NOT_YET_RECRUITING
-
Measurement and Impact of Physical Impairment in Amyotrophic Lateral Sclerosis: Use of Digital Technologies - A Precision ALS Project
NCT06820008 ·Status: RECRUITING
-
Investigation of Cannabinoid 2-receptor Expression in the Brain and Spine of ALS-patients Compared to Healthy Controls With PET (18F-RoSMALS)
NCT05880563 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Registration Study of Amyotrophic Lateral Sclerosis (ALS) in Mainland China
NCT04328675 ·Status: UNKNOWN
-
Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS) Who Met Severity Classification III
NCT00415519 ·Status: COMPLETED ·Phase: PHASE3
-
Spinal Interneuron Excitability in ALS
NCT02429492 ·Status: COMPLETED ·Phase: NA
-
COVID-19 Amyotrophic Lateral Sclerosis (ALS) Registry
NCT04559009 ·Status: COMPLETED
-
Analysis of Human ALS Tissues and Registry of ALS Patients
NCT05067179 ·Status: RECRUITING
-
Methodology Study of Novel Outcome Measures to Assess Progression of ALS
NCT02611674 ·Status: COMPLETED
-
Natural History and Clinical Features of Amyotrophic Lateral Sclerosis (ALS)
NCT04454892 ·Status: RECRUITING
-
Exercise and Disease Progression in Amyotrophic Lateral Sclerosis Patients
NCT03326622 ·Status: COMPLETED ·Phase: NA
-
Determining the Safety of L-serine in ALS
NCT01835782 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
HEALEY ALS Platform Trial - Regimen E SLS-005 - Trehalose
NCT05136885 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Explore Neuroprotective Effect of Lipoic Acid in Amyotrophic Lateral Sclerosis
NCT04518540 ·Status: UNKNOWN ·Phase: NA
-
Influence of Olfacto-gustatory Sensoriality on the Nutritional Status of Patients With Amyotrophic Lateral Sclerosis
NCT06608004 ·Status: RECRUITING
-
In-situ Cytokines Expression in the CNS in Amyotrophic Lateral Sclerosis (ALS)
NCT02582385 ·Status: COMPLETED
-
Rehabilitative Trial With tDCS in Amyotrophic Lateral Sclerosis
NCT03293394 ·Status: COMPLETED ·Phase: NA